Literature DB >> 22391647

Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?

Gernot Bonkat1, Malte Rieken, Georg Müller, Alexander Roosen, Fabian P Siegel, Reno Frei, Stephen Wyler, Thomas Gasser, Alexander Bachmann, Andreas F Widmer.   

Abstract

PURPOSE: Ureteral stents are frequently associated with side effects. Most patients suffer from storage lower urinary tract symptoms (LUTS). Storage LUTS are commonly attributed to the irritation of the trigone, smooth muscle spasm or a combination of factors. The relationship between microbial ureteral stent colonization (MUSC) and de novo or worsening storage LUTS has not been investigated yet.
METHODS: Five hundred ninety-one polyurethane ureteral stents from 275 male and 153 female patients were prospectively evaluated. The removed stents were sonicated to dislodge adherent microorganisms. Urine flow cytometry was performed to detect pyuria. A standardized urinary symptom questionnaire was given to all patients.
RESULTS: Thirty-five per cent of male and 28% of female cases showed de novo or worsened storage LUTS. MUSC was more common in patients with storage LUTS compared to patients without storage LUTS (men: 26 vs. 13%, respectively, P < 0.05; women: 63 vs. 48%, respectively, P = 0.13). Pyuria was significantly more common in patients with storage LUTS compared to patients without storage LUTS (men: 55 vs. 40%, respectively, P < 0.05; women: 70 vs. 45%, respectively, P < 0.05). No significant correlation was observed between the detected genera of microorganisms and storage LUTS.
CONCLUSIONS: Our data show a significant association between MUSC- and stent-related de novo experienced or worsened storage LUTS in men. The incidence of MUSC is most common in both female and male patients with storage LUTS and accompanying pyuria. In these patients, a combination of antibiotics and anti-inflammatory drugs may be regarded as treatment option.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391647     DOI: 10.1007/s00345-012-0849-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  30 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 2.  The role of biofilm infection in urology.

Authors:  P Tenke; B Kovacs; M Jäckel; E Nagy
Journal:  World J Urol       Date:  2006-01-10       Impact factor: 4.226

3.  Cutoff values for bacteria and leukocytes for urine flow cytometer Sysmex UF-1000i in urinary tract infections.

Authors:  Fabio Manoni; Lucia Fornasiero; Mauro Ercolin; Agostino Tinello; Melissa Ferrian; Paolo Hoffer; Sara Valverde; Gianluca Gessoni
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

Review 4.  Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.

Authors:  Alastair D Lamb; Sarah L Vowler; Richard Johnston; Nick Dunn; Oliver J Wiseman
Journal:  BJU Int       Date:  2011-03-31       Impact factor: 5.588

5.  Ureteral stents: impact of diameter and composition on patient symptoms.

Authors:  J V Candela; G C Bellman
Journal:  J Endourol       Date:  1997-02       Impact factor: 2.942

6.  Late complications of ureteral stents.

Authors:  A Ringel; S Richter; M Shalev; I Nissenkorn
Journal:  Eur Urol       Date:  2000-07       Impact factor: 20.096

7.  Beware! Fungal urosepsis may follow endoscopic intervention for prolonged indwelling ureteral stent.

Authors:  Gagan Gautam; A K Singh; Rajeev Kumar; A K Hemal; Atul Kothari
Journal:  J Endourol       Date:  2006-07       Impact factor: 2.942

8.  The indwelling ureteric stent: a 'friendly' procedure with unfriendly high morbidity.

Authors:  S Richter; A Ringel; M Shalev; I Nissenkorn
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

9.  Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.

Authors:  Apostolos Apostolidis; Ciaran M Brady; Yiangos Yiangou; John Davis; Clare J Fowler; Praveen Anand
Journal:  Urology       Date:  2005-02       Impact factor: 2.649

10.  Conditioning film deposition on ureteral stents after implantation.

Authors:  C Tieszer; G Reid; J Denstedt
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

View more
  7 in total

1.  Comparison of the roll-plate and sonication techniques in the diagnosis of microbial ureteral stent colonisation: results of the first prospective randomised study.

Authors:  G Bonkat; O Braissant; M Rieken; G Müller; R Frei; Andre van der Merwe; F P Siegel; T C Gasser; S Wyler; A Bachmann; A F Widmer
Journal:  World J Urol       Date:  2012-10-05       Impact factor: 4.226

2.  Influence of biofilms on morbidity associated with short-term indwelling ureteral stents: a prospective observational study.

Authors:  Patrick Betschart; Valentin Zumstein; Matthias T Buhmann; Werner C Albrich; Oliver Nolte; Sabine Güsewell; Hans-Peter Schmid; Qun Ren; Dominik Abt
Journal:  World J Urol       Date:  2018-11-27       Impact factor: 4.226

3.  Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation.

Authors:  Gernot Bonkat; Andreas F Widmer; Malte Rieken; Andre van der Merwe; Olivier Braissant; Georg Müller; Stephen Wyler; Reno Frei; Thomas C Gasser; Alexander Bachmann
Journal:  World J Urol       Date:  2012-08-25       Impact factor: 4.226

4.  Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.

Authors:  Shucheng Liu; Ying Yu; Yang Gao; Xiong Yang; Zili Pang
Journal:  Urolithiasis       Date:  2015-08-05       Impact factor: 3.436

5.  Characterization of nanostructured ureteral stent with gradient degradation in a porcine model.

Authors:  Xiaoqing Wang; Hongli Shan; Jixue Wang; Yuchuan Hou; Jianxun Ding; Qihui Chen; Jingjing Guan; Chunxi Wang; Xuesi Chen
Journal:  Int J Nanomedicine       Date:  2015-04-20

6.  Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial.

Authors:  Carlos Torrecilla; Jaime Fernández-Concha; José R Cansino; Juan A Mainez; José H Amón; Simbad Costas; Oriol Angerri; Esteban Emiliani; Miguel A Arrabal Martín; Miguel A Arrabal Polo; Ana García; Manuel C Reina; Juan F Sánchez; Alberto Budía; Daniel Pérez-Fentes; Félix Grases; Antonia Costa-Bauzá; Jordi Cuñé
Journal:  BMC Urol       Date:  2020-06-05       Impact factor: 2.264

7.  Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load.

Authors:  Matthias T Buhmann; Dominik Abt; Oliver Nolte; Thomas R Neu; Sebastian Strempel; Werner C Albrich; Patrick Betschart; Valentin Zumstein; Antonia Neels; Katharina Maniura-Weber; Qun Ren
Journal:  Microbiome       Date:  2019-04-13       Impact factor: 14.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.